| |
| |
|
| Insider
Information: |
West Michael D |
| Relationship: |
Chief Executive Officer |
| City: |
Worcester |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
979,694 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$830,956 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
979,694 |
|
|
| Total
Value |
$830,956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
Co-Chief Executive Off... |
2018-09-17 |
893,913 |
2010-03-19 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Director |
2015-12-30 |
43,799 |
|
0 |
Premium* |
|
|
Agex Therapeutics, Inc. |
AGE |
Chief Executive Officer |
2023-03-11 |
41,982 |
2018-12-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2023-03-11 |
4 |
D |
$0.59 |
$625 |
D/D |
(1,060) |
41,982 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2023-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
43,042 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-12-11 |
4 |
D |
$0.59 |
$638 |
D/D |
(1,081) |
39,917 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
40,998 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-09-11 |
4 |
D |
$0.56 |
$608 |
D/D |
(1,081) |
44,503 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
45,584 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
41,696 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
D |
$0.69 |
$887 |
D/D |
(1,281) |
40,415 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-12-11 |
4 |
D |
$0.64 |
$686 |
D/D |
(1,081) |
38,571 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
39,652 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-09-11 |
4 |
D |
$1.00 |
$1,078 |
D/D |
(1,081) |
36,527 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
37,608 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
35,564 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-11 |
4 |
D |
$1.53 |
$1,654 |
D/D |
(1,081) |
34,483 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-03-11 |
4 |
D |
$2.03 |
$2,607 |
D/D |
(1,284) |
32,439 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
33,723 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-11 |
4 |
D |
$1.69 |
$1,827 |
D/D |
(1,081) |
30,598 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
31,679 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
29,635 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-09-11 |
4 |
D |
$0.81 |
$875 |
D/D |
(1,081) |
28,554 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-06-11 |
4 |
D |
$0.80 |
$865 |
D/D |
(1,081) |
26,510 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-06-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
27,591 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-03-11 |
4 |
D |
$0.88 |
$4,463 |
D/D |
(5,085) |
24,446 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
29,551 |
0 |
- |
|
| AGE |
Agex Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2018-12-10 |
4 |
B |
$3.86 |
$15,443 |
D/D |
4,000 |
15,460 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
